Substrates for peptidase M9G.026: dactylysin
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amyloid beta A4 protein | P05067 | 683-692 | Peptide-Leu688+Val-Phe-Phe-Ala | N | MS | His | Gln | Lys | Leu | Val | Phe | Phe | Ala | Clamagirand et al., 2002 | ||
| Amyloid beta A4 protein | P05067 | 683-692 | Peptide-Phe690+Phe-Ala | N | MS | Lys | Leu | Val | Phe | Phe | Ala | - | - | Clamagirand et al., 2002 | ||
| angiotensin-2 | P01019 | 34-41 | Asp-Arg-Val-Tyr+Ile-His-Pro-Phe | N | Ala | Arg | Val | Tyr | Ile | His | Pro | Phe | Clamagirand et al., 2004 | |||
| atrial natriuretic factor 21-28 | P01160 | 134-143 | Leu-Gly-Cys-Asn-Ser+Phe-Arg-Tyr | N | Gly | Cys | Asn | Ser | Phe | Arg | Tyr | - | Clamagirand et al., 2004 | |||
| Beta-amyloid protein 40 | P05067 | 672-711 | Peptide-His685+Gln-Peptide | N | MS | Glu | Val | His | His | Gln | Lys | Leu | Val | Clamagirand et al., 2002 | ||
| bradykinin | P01042 | 381-389 | Arg-Pro-Pro-Gly+Phe-Ser-Pro-Phe-Arg | N | Arg | Pro | Pro | Gly | Phe | Ser | Pro | Phe | Clamagirand et al., 2004 | 16520 | ||
| Bradykinin | P01042 | 381-389 | Peptide-Pro387+Phe-Arg | N | NT | Gly | Phe | Ser | Pro | Phe | Arg | - | - | Carvalho et al., 1992 | ||
| dynorphin A1-16 | P01214 | 209-224 | Tyr-Gly-Gly-Phe+Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn | N | Tyr | Gly | Gly | Phe | Leu | Arg | Arg | Ile | Clamagirand et al., 2004 | |||
| Kermit | Asp-Val-Asp-Glu-Arg-Asp-Val-Arg-Gly-Phe-Ala-Ser+Phe-Leu-NH2 | N | Gly | Phe | Ala | Ser | Phe | Leu | - | - | Clamagirand et al., 2004 | |||||
| Leu-enkephalin | P01213 | 207-211 | Tyr-Gly-Gly209+Phe-Leu-NH2 | N | MS | - | Tyr | Gly | Gly | Phe | Leu | NH2 | - | Clamagirand et al., 2002 | ||
| Litorin | P08945 | 1-9 | Peptide-Gly6+His-Phe-Met-NH2 | N | NT | Trp | Ala | Val | Gly | His | Phe | Met | NH2 | Carvalho et al., 1992 | ||
| Litorin | P08945 | 1-9 | Peptide-His7+Phe-Met-NH2 | N | NT | Ala | Val | Gly | His | Phe | Met | NH2 | - | Carvalho et al., 1992 | ||
| neurokinin A | His-Lys-Thr-Asp-Ser-Phe-Val-Gly+Leu-Met-NH2 | N | Ser | Phe | Val | Gly | Leu | Met | - | - | Clamagirand et al., 2004 | |||||
| neuromedin-B | P08949 | 47-56 | Peptide-Gly53+His-Phe-Met-NH2 | N | NT | Trp | Ala | Thr | Gly | His | Phe | Met | NH2 | Carvalho et al., 1992 | ||
| neuromedin-B | P08949 | 47-56 | Peptide-His54+Phe-Met-NH2 | N | NT | Ala | Thr | Gly | His | Phe | Met | NH2 | - | Carvalho et al., 1992 | ||
| Neuromedin-C | P07492-1 | 41-50 | Peptide-Gly47+His-Leu-Met-NH2 | N | NT | Trp | Ala | Val | Gly | His | Leu | Met | NH2 | Carvalho et al., 1992 | ||
| Neuromedin-C | P07492-1 | 41-50 | Peptide-His48+Leu-Met-NH2 | N | NT | Ala | Val | Gly | His | Leu | Met | NH2 | - | Carvalho et al., 1992 | ||
| PGLa antimicrobial peptide | Q99134 | 36-59 | peptide-Lys12+Ile-peptide | P | Ile | Ala | Gly | Lys | Ile | Ala | Lys | Val | Clamagirand et al., 2004 | 16523 | ||
| somatostatin-14 | P61278 | 103-116 | Ala-Gly-Cys-Lys-Asn-Phe+Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys | N | Cys | Lys | Asn | Phe | Phe | Trp | Lys | Thr | Clamagirand et al., 2004 | 16524 | ||
| substance P | P20366 | 58-68 | Arg-Pro-Lys-Pro-Gln-Gln-Phe+Phe-Gly-Leu-Met-NH2 | N | Lys | Gln | Gln | Phe | Phe | Gly | Leu | Met | Clamagirand et al., 2004 | |||
| substance P | P20366 | 58-68 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly+Leu-Met-NH2 | N | Gln | Phe | Phe | Gly | Leu | Met | NH2 | - | Clamagirand et al., 2004 | |||
| [Arg0,Leu5,Arg6]-enkephalin | P01213 | 174-180 | Arg-Tyr-Gly-Gly-Phe+Leu-Arg-NH2 | N | Tyr | Gly | Gly | Phe | Leu | Arg | - | - | Clamagirand et al., 2004 | |||
| [Leu5,Arg6]-enkephalin | P01213 | 175-179 | Tyr-Gly-Gly-Phe+Leu-Arg-NH2 | N | Tyr | Gly | Gly | Phe | Leu | Arg | - | - | Clamagirand et al., 2004 |
